Etofibrate

Etofibrate

Etofibrate (pronounced: e-toe-fye-brate) is a type of lipid-lowering agent that is used to treat hyperlipidemia, a condition characterized by abnormally high levels of lipids in the blood.

Etymology

The term "Etofibrate" is derived from the combination of two active substances, etofylline and fibric acid. The suffix "-brate" is commonly used for drugs that are fibric acid derivatives.

Usage

Etofibrate is used to lower the levels of cholesterol and triglycerides in the blood. It is particularly effective in treating hypertriglyceridemia, a condition where the triglyceride levels are elevated.

Mechanism of Action

Etofibrate works by increasing the activity of lipoprotein lipase, an enzyme that helps to break down lipids in the blood. This results in a decrease in the levels of harmful lipids and an increase in the levels of beneficial lipids.

Side Effects

Like all medications, Etofibrate can cause side effects. Common side effects include nausea, diarrhea, and stomach pain. In rare cases, it can cause serious side effects such as muscle pain, liver damage, and pancreatitis.

Related Terms

• Hyperlipidemia
• Cholesterol
• Triglycerides
• Lipoprotein lipase
• Hypertriglyceridemia
• Etofylline
• Fibric acid

External links

• Medical encyclopedia article on Etofibrate
• Wikipedia's article - Etofibrate

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski